IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ponoi II Management, LLC

Q3 2022 Holdings

Filed 2022-11-14 | 4 holdings | $38.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$17.0K1,298,90844.4%
Revolution Medicines Inc(RVMD)COM76155X100$13.5K685,01135.3%
Nurix Therapeutics Inc(NRIX)COM67080M103$4.3K327,12311.1%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$3.5K145,4019.1%